Live-Cell Imaging Assay for Protein Trapping Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer therapies lack specificity, leading to severe side effects due to targeting all rapidly dividing cells, and there is a need for new methods to identify compounds that can trap proteins like PARP enzymes on DNA to enhance cancer cell killing and overcome resistance mechanisms.
Innovation Solution
A method involving live-cell imaging and local laser micro-irradiation to measure the ability of compounds to trap proteins on DNA, specifically identifying inhibitors that enhance the trapping of PARP1, PARP2, and other chromatin/DNA-damage associating proteins, thereby sensitizing cancer cells and promoting cell killing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional chemotherapeutics target all rapidly dividing cells, then cancer cells are killed, but healthy dividing cells are also damaged causing severe side effects
Solution Approach 1:
The patent segments the cancer treatment approach by targeting specific molecular pathways (PARP enzymes, ALC1, chromatin remodelers) rather than all dividing cells. This allows selective disruption of DNA repair mechanisms in cancer cells while sparing healthy cells that do not rely on these specific pathways, thereby reducing side effects while maintaining therapeutic effectiveness.
Solution Approach 2:
The patent applies local quality by introducing detectably labelled proteins that specifically bind to DNA damage sites. This enables localized detection and measurement of protein trapping at specific genomic locations, allowing for precise assessment of compound effects on DNA repair processes without affecting the entire cell population uniformly.
2Object-affected harmful factors
If new targeted cancer treatments are developed, then specificity and reduced side effects are achieved, but the number of available treatments remains low
Solution Approach 1:
The patent employs self-service through the use of detectably labelled proteins that automatically bind to their target DNA damage sites and compounds of interest. This self-binding capability eliminates the need for complex external detection systems, enabling high-throughput screening of multiple compounds simultaneously, thereby accelerating the discovery process and increasing the number of available targeted treatments.
Solution Approach 2:
The patent utilizes parameter changes by measuring accumulation and residence time of labelled proteins as quantitative indicators of compound activity. By monitoring these temporal parameters, the assay can rapidly evaluate multiple compounds and identify promising candidates for further development, thus increasing treatment availability.
3Reliability
If protein trapping capability is enhanced, then cancer cell killing is potentiated, but measurement and detection of trapping effects become challenging
Solution Approach 1:
The patent introduces detectably labelled proteins as intermediaries that mediate between the compound-induced protein trapping and the detection system. These labelled proteins specifically bind to trapped proteins at DNA damage sites, converting the invisible molecular trapping event into a detectable signal that can be quantified by imaging or flow cytometry, thereby simplifying measurement while preserving the potentiation of cancer cell killing.
4Measurement precision
If live-cell imaging and laser micro-irradiation are used to measure protein trapping, then direct measurement capability is achieved, but assay complexity increases
Solution Approach 1:
The patent segments the complex assay into distinct functional modules: (1) compound treatment, (2) DNA damage induction via laser micro-irradiation, (3) protein trapping, and (4) detection of labelled proteins. This modular segmentation allows each step to be optimized independently and facilitates high-throughput implementation, reducing overall assay complexity while maintaining measurement precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the identification of compounds that increase protein trapping, potentially leading to more effective and specific cancer treatments with reduced side effects by enhancing cellular cytotoxicity and overcoming treatment resistance.
Implementation Method 1
local laser micro-irradiation of nuclear DNA
Implementation Method 2
detectably labelled protein
Data Source
AI summary
Screening methods as well as kits for identifying compounds capable of trapping proteins, e.g. proteins involved in DNA repair, are provided. The methods provide the use of live-cell imaging and local laser micro-irradiation of nuclear DNA in an assay to measure the effects of compounds on the trapping of 5 proteins on DNA. The disruption, e.g. inhibition, of specific proteins, such as poly-(ADP-ribose) polymerases or ALC1 enzyme, leads to trapping on chromatin and/or at DNA damage sites. This inhibits essential cellular functions, e.g. DNA damage repair, and can potentiate cancer cell killing.